Globe Life (GL) Reports Q3 Earnings: What Key Metrics Have to Say

Globe Life (GL) reported $1.46 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 5.1%. EPS of $3.49 for the same period compares to $2.71 a year ago.The reported revenue represents a surprise of -0.66% over the Zacks Consensus Estimate of $1.47 billion. With the consensus EPS estimate being $3.05, the EPS surprise was +14.43%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Globe Life performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Total premium: $1.17 billion versus the six-analyst average estimate of $1.18 billion. The reported number represents a year-over-year change of +4.8%. Revenue- Net investment income: $284.96 million compared to the $285.38 million average estimate based on six analysts. The reported number represents a change of +6.8% year over year. Revenue- Life premium: $818.64 million versus $824.21 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +3.9% change. Revenue- Health premium: $353.96 million versus $354.32 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +6.9% change. Revenue- Other income (loss): $0.04 million compared to the $0.09 million average estimate based on four analysts. The reported number represents a change of -16% year over year. Life Underwriting Margin - Other: $32.96 million compared to the $30.09 million average estimate based on three analysts. Life Underwriting Margin - Liberty National: $44.70 million compared to the $32.35 million average estimate based on three analysts. Life Underwriting Margin - Direct to Consumer: $88.28 million compared to the $64.11 million average estimate based on three analysts. Life Underwriting Margin - American Income: $221.25 million compared to the $199.27 million average estimate based on three analysts. Revenue - Health premium- Family Heritage: $107.82 million versus $108.40 million estimated by three analysts on average. Revenue- Health Premium- United American: $149.51 million compared to the $148.72 million average estimate based on three analysts. Revenue - Health premium- Direct Response: $18.07 million versus the three-analyst average estimate of $17.69 million. View all Key Company Metrics for Globe Life here>>>Shares of Globe Life have returned +2.7% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Globe Life Inc. (GL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks